181 related articles for article (PubMed ID: 36256500)
1. Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension.
Schroeder L; Monno P; Unger M; Ackerl J; Shatilova O; Schmitt J; Dresbach T; Mueller A; Kipfmueller F
ESC Heart Fail; 2023 Feb; 10(1):385-396. PubMed ID: 36256500
[TBL] [Abstract][Full Text] [Related]
2. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Kakihana Y; Nishida O; Taniguchi T; Okajima M; Morimatsu H; Ogura H; Yamada Y; Nagano T; Morishima E; Matsuda N;
Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
[TBL] [Abstract][Full Text] [Related]
4. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T;
J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682
[TBL] [Abstract][Full Text] [Related]
5. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
Tokunaga C; Hiramatsu Y; Kanemoto S; Takahashi-Igari M; Abe M; Horigome H; Sakakibara Y
Ann Thorac Surg; 2013 May; 95(5):1685-8. PubMed ID: 23506630
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
Schroeder L; Holcher S; Leyens J; Geipel A; Strizek B; Dresbach T; Mueller A; Kipfmueller F
Eur J Pediatr; 2023 Jul; 182(7):3165-3174. PubMed ID: 37100959
[TBL] [Abstract][Full Text] [Related]
7. Use of low-dose β
Sakai M; Jujo S; Kobayashi J; Ohnishi Y; Kamei M
J Cardiothorac Surg; 2019 Jul; 14(1):145. PubMed ID: 31345252
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
Sezai A; Osaka S; Yaoita H; Ishii Y; Arimoto M; Hata H; Shiono M
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):957-64. PubMed ID: 26254752
[TBL] [Abstract][Full Text] [Related]
9. Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.
Oka E; Iwasaki YK; Maru E; Fujimoto Y; Ito-Hagiwara K; Hayashi H; Yamamoto T; Yodogawa K; Hayashi M; Shimizu W
Circ J; 2019 Mar; 83(4):793-800. PubMed ID: 30814430
[TBL] [Abstract][Full Text] [Related]
10. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
[TBL] [Abstract][Full Text] [Related]
11. Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study.
Miyake K; Fujita Y; Yoshizawa S; Tomita M; Miyazu M; Sento Y; Yoshimura S; Sobue K
J Anesth; 2016 Apr; 30(2):331-6. PubMed ID: 26699148
[TBL] [Abstract][Full Text] [Related]
12. Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series.
Ditali V; Garatti L; Morici N; Villanova L; Colombo C; Oliva F; Sacco A
ESC Heart Fail; 2022 Feb; 9(1):766-770. PubMed ID: 34962097
[TBL] [Abstract][Full Text] [Related]
13. Landiolol Hydrochloride Rapidly Controls Junctional Ectopic Tachycardia After Pediatric Heart Surgery.
Yoneyama F; Tokunaga C; Kato H; Nakajima T; Mathis BJ; Sakamoto H; Hiramatsu Y
Pediatr Crit Care Med; 2018 Aug; 19(8):713-717. PubMed ID: 29677032
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function.
Shinohara M; Wada R; Yano K; Akitsu K; Koike H; Kinoshita T; Suzuki T; Fujino T; Ikeda T
Int Heart J; 2020 Sep; 61(5):944-950. PubMed ID: 32921677
[TBL] [Abstract][Full Text] [Related]
15. Control of Heart Rate in Infant and Child Tachyarrhythmia With Reduced Cardiac Function Using Landiolol (HEARTFUL) - Results of a Prospective, Multicenter, Uncontrolled Clinical Study.
Sagawa K; Suzuki T; Takei K; Miura M; Ueda H; Horigome H; Ono H; Ohashi N; Sato S; Fukunaga H; Aoki H; Miyazaki A; Sakaguchi H; Morishima E; Oki K; Sumitomo N
Circ J; 2022 Dec; 87(1):130-138. PubMed ID: 35979562
[TBL] [Abstract][Full Text] [Related]
16. Landiolol: A Review in Tachyarrhythmias.
Syed YY
Drugs; 2018 Mar; 78(3):377-388. PubMed ID: 29470800
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
Taenaka N; Kikawa S
Am J Cardiovasc Drugs; 2013 Oct; 13(5):353-64. PubMed ID: 23818039
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies.
Ashida A; Ozaki N; Kishi K; Odanaka Y; Nemoto S; Konishi H; Ashida A
Pediatr Cardiol; 2021 Dec; 42(8):1700-1705. PubMed ID: 34097085
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
Matsuishi Y; Mathis BJ; Shimojo N; Kawano S; Inoue Y
Vasc Health Risk Manag; 2020; 16():111-123. PubMed ID: 32308404
[TBL] [Abstract][Full Text] [Related]
20. Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy.
Mori K; Yamada K; Fukuda T; Mitsui T; Kitamura T; Yamaguchi D; Ando J; Wada I; Nomura S; Shimizu N; Seto Y
Surg Today; 2014 May; 44(5):848-54. PubMed ID: 23674201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]